Dharne Mahesh Shantappa, Munot Hitendra, Pujari Rajesh, Kakrani Arjun Lal, Patole Milind Shivajirao, Shouche Yogesh Shripad
Molecular Biology Unit, National Centre for Cell Science, Pune.
Indian J Pathol Microbiol. 2007 Oct;50(4):740-8.
Scarce reports relying on rapid urease test, serology and histopathology are currently known for H. pylori from Western India, Maharashtra. We investigated H. pylori genotypes at molecular level in gastro-duodenal disease population during the years 2002-2005. H. pylori presence was scored by polymerase chain reaction in the infected biopsies (n = 95) in various gastric diseases. H. pylori specific 16S rDNA gene amplification based preliminary identification coupled with protein coding gene amplification scores were assessed for the incidence. H. pylori 16S rDNA and 7 housekeeping genes were detected in all biopsies, whereas 71.18% and 28% found to be cagA positive and negative respectively. The vacA toxigenic alleles (vacA s1) and middle region subunit vac m1a were found in 54%, and 59% patients. However, the iceA1 was present in 40.06%; the iceA2 was less i.e. in 13.5% patients. The most common allelic combinations in different age groups irrespective of disease types were 13-30, 31-45, 46-60 and 61-73 were cagA-vac m1a-vacA s1-iceA1. In our analysis, PCR was found to be 100% accurate in detecting H. pylori in gastric biopsies. Among West Indian population H. pylori was found to be present, irrespective of any correlation with the genotype and gender of patients with the clinical outcome. However, the genotype incidences were related to age of the patients, wherein the age group ranging from 46 to 60 years was found be susceptible for H. pylori infection.
目前,来自印度西部马哈拉施特拉邦的关于幽门螺杆菌的报告很少,这些报告依赖快速尿素酶试验、血清学和组织病理学。我们在2002年至2005年期间对胃十二指肠疾病人群中的幽门螺杆菌基因型进行了分子水平研究。通过聚合酶链反应对各种胃病中受感染的活检组织(n = 95)中的幽门螺杆菌存在情况进行评分。评估基于幽门螺杆菌特异性16S rDNA基因扩增的初步鉴定以及蛋白质编码基因扩增评分的发生率。在所有活检组织中均检测到幽门螺杆菌16S rDNA和7个管家基因,而分别发现71.18%和28%的组织cagA呈阳性和阴性。54%的患者检测到vacA产毒等位基因(vacA s1),59%的患者检测到中间区域亚基vac m1a。然而,iceA1的存在率为40.06%;iceA2的存在率较低,即仅在13.5%的患者中存在。无论疾病类型如何,不同年龄组中最常见的等位基因组合在13 - 30岁、31 - 45岁、46 - 60岁和61 - 73岁年龄组中均为cagA - vac m1a - vacA s1 - iceA1。在我们的分析中,发现聚合酶链反应在检测胃活检组织中的幽门螺杆菌时准确率为100%。在西印度人群中发现存在幽门螺杆菌,无论其与患者的基因型和性别以及临床结果有无关联。然而,基因型发生率与患者年龄有关,其中46至60岁年龄组被发现易感染幽门螺杆菌。